Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of ANKASCIN 568-P Products on Decreasing HbA1c and Regulating Blood Glucose
Sponsor: SunWay Biotech Co., LTD.
Summary
This study is a randomized, double-blind, placebo-controlled, parallel-controlled trial (24 weeks in total), divided into three periods (screening, treatment, and discontinuation follow-up)
Official title: Effect of ANKASCIN 568-P Products on Decreasing HbA1c and Regulating Blood Glucose- A Double-blind, Placebo-controlled Clinical Research
Key Details
Gender
All
Age Range
20 Years - Any
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2023-04-01
Completion Date
2025-10-31
Last Updated
2025-08-28
Healthy Volunteers
No
Conditions
Interventions
ANKASCIN 568-P Red yeast rice capsules
Product ingredients: ANKASCIN 568-P red yeast rice product 440 mg,microcrystalline ,cellulose,Maltodextrin; capsule shell composition: HPMC (hydroxypropyl methylcellulose), purified water, titanium dioxide, gellan gum.
Placebo Capsules
Maltodextrin was used as a placebo
Locations (1)
Tri-Service General Hospital, National Defense Medical Center, Taipei city,
Taipei, Taiwan